The purpose of this work is to develop an experimental system that would control acoustic artifacts when evaluating the clinical outcome of the noninvasive, ultrasound administered neurostimulation.
Shockwave Medical picked up $45 million in a Series C round, which will propel the development and commercialization of its ultrasound balloon device for the treatment of peripheral artery disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback